Decreased corticotropin-releasing hormone (crh) concentrations in the cerebrospinal fluid of eucortisolemic suicide attempters

Journal of Psychiatric Research

Volumn 35, Issue 1, 2001, Pages 1-9

  Brunner, Jürgen ^a   Stalla, Günter K ^a   Stalla, Johanna ^a   Uhr, Manfred ^a   Grabner, Andreas ^a   Wetter, Thomas C ^a   Bronisch, Thomas ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Cerebrospinal fluid; Corticotropin releasing hormone; Cortisol; Hpa system; Suicide attempt

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE;

ADULT; AFFECTIVE NEUROSIS; AGED; ARTICLE; BLOOD LEVEL; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; LUMBAR PUNCTURE; MALE; MENTAL PATIENT; NEUROLOGIC DISEASE; PERSONALITY DISORDER; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SCHIZOPHRENIA; SUICIDE ATTEMPT; TECHNIQUE;

ADULT; BRAIN DISEASES; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MENTAL DISORDERS; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; SPINAL PUNCTURE; SUICIDE, ATTEMPTED;

EID: 0035081290     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(01)00007-3     Document Type: Article

References (53)

1. Elevated CSF CRF in suicide victims
2. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia
3. CSF corticotropin-releasing hormone and somatostatin in major depression; response to antidepressant treatment and relapse
4. Cerebrospinal fluid studies of bipolar patients with and without a history of suicide attempts
5. Neurobiologische Korrelate suizidalen Verhaltens
6. Plasma corticotropin-releasing factor in depressive disorders
7. Corticotropin-releasing factor immunoreactivity in post-mortem brain from depressed suicides
8. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginin-vasopressin in patients with major depression
9. Cerebrospinal fluid corticotropin-releasing factor increases following haloperidol withdrawal in chronic schizophrenia
10. CSF corticotropin-releasing factor-like immunoactivity in chronic pain patients with and without major depression
11. Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans
12. Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression
13. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls; response to amitriptyline treatment
14. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
15. Corticotropin-releasing factor binding sites in cortex of depressed suicides
16. Chlordiazepoxide attenuates stress-induced accumulation of corticotropin-releasing factor mRNA in the paraventricular nucleus
17. Chlordiazepoxide attenuates stress-induced activations of neurons, corticotropin-releasing factor (CRF) gene transcription and CRF biosynthesis in the paraventricular nucleus
18. A diurnal rhythm in cerebrospinal fluid corticotrophin-releasing hormone different from the rhythm of pituitary-adrenal activity
19. In vitro and in vivo effects of the triazolbenzodiazepine alprazolam on hypothalamic-pituitary-adrenal function; pharmacological and clinical implications
20. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression; potential clinical implications
21. Diurnal variation of cerebrospinal fluid immunoreactive corticotropin-releasing hormone levels in healthy volunteers
22. Corticotropin-releasing factor, norepinephrine, and stress
23. Benzodiazepines attenuate the pituitary-adrenal responses to corticotrophin-releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome
24. Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression
25. The dexamethasone suppression test as an indicator of suicide; a meta-analysis
26. Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge
27. Localization and quantification of pro-opiomelanocortin mRNA and glucocorticoid receptor mRNA in pituitaries of suicide victims
28. 1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: Implications for the neurobiology of depression
29. Hypothalamic-pituitary-adrenal and -thyroid axis dysfunctions and decrements in the availability of L-tryptophan as biological markers of suicidal ideation in major depressed females
30. Urinary catecholamines and cortisol in parasuicide
31. The neurobiology of suicide
32. Differential effects of haloperidol on the rat pituitary; decreased biosynthesis, processing and release of anterior lobe pro-opiomelanocortin
33. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims
34. The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: Implications for a role for CRF in the pathogenesis of anxiety disorders
35. Effects of carbamazepine on pituitary-adrenal function in healthy volunteers
36. Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls
37. Hypothalamic-pituitary-adrenal axis function and platelet serotonin concentrations in depressed patients
38. Effects of corticotropin-releasing factor on brain serotonergic activity
39. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system
40. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide
41. Central administration of corticotropin-releasing hormone profoundly stimulates rat hippocampal serotonergic neurotransmission and behavioral activity; no effect of adrenalectomy
42. Corticotropin releasing factor administered into the ventricular CSF stimulates the pituitary-adrenal axis
43. Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression
44. Neuropeptides in relation to suicidal behavior in depression
45. CSF corticotropin-releasing hormone in depressed patients and normal control subjects
46. Hypothalamic-pituitary-adrenal axis and monoamine transmitter activity in depression; a pilot study of central and peripheral effects of electroconvulsive therapy
47. Corticotropic-releasing hormone and serotonin interact in the human brainstem; behavioral implications
48. Chronic administration of the triazolbenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems
49. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus; a hybridization biochemical study in the rat
50. Corticotropin-releasing factor in humans. I. CRF stimulation in normals and CRF radioimmunoassay
51. HPA-related CSF neuropeptides in suicide attempters
52. Forebrain pathways mediating stress-induced hormone secretion
53. Alterations of corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt